Show simple item record

dc.creatorKuo, Bryan
dc.creatorKoransky, Alison
dc.creatorVaz, Cherie Lisa
dc.date.accessioned2023-09-13T16:51:22Z
dc.date.available2023-09-13T16:51:22Z
dc.date.issued2023-03-24
dc.identifier.citationBryan Kuo, Alison Koransky, Cherie Lisa Vaz Wicks, Adrenal Crisis as An Adverse Reaction to Zoledronic Acid in a Patient With Primary Adrenal Insufficiency: A Case Report and Literature Review, AACE Clinical Case Reports, Volume 9, Issue 2, 2023, Pages 32-34, ISSN 2376-0605, https://doi.org/10.1016/j.aace.2022.12.003. (https://www.sciencedirect.com/science/article/pii/S2376060522000876)
dc.identifier.issn2376-0605
dc.identifier.urihttp://hdl.handle.net/20.500.12613/9036
dc.description.abstractBackground/Objective: Adrenal crisis is a medical emergency and an acute complication of adrenal insufficiency (AI). It can be triggered by stressors such as infection, dehydration, trauma, or surgery. Case Report: We present a case of a 70-year-old woman with a history of Addison’s disease, who presented in adrenal crisis within 24 hours after receiving her first infusion of zoledronic acid. No trigger was identified after extensive evaluation, making infusion with zoledronic acid the most likely cause of adrenal crisis. Discussion: Adverse reactions to medications can potentially trigger adrenal crisis. The present case report demonstrates that intravenous bisphosphonates can cause an acute phase reaction that may lead to adrenal crisis. Given the increased risk of osteoporosis in patients with AI there is an increased likelihood of prescription of intravenous bisphosphonates in this patient population. Conclusion: Patients with AI undergoing infusion with zoledronic acid may require an increased dose of glucocorticoid prior to infusion and may need to undergo monitoring post infusion for possible adrenal crisis.
dc.format.extent3 pages
dc.languageEnglish
dc.language.isoeng
dc.relation.ispartofOpen Access Publishing Fund
dc.relation.haspartAACE Clinical Case Reports, Vol. 9, Iss. 2
dc.relation.isreferencedbyElsevier
dc.rightsAttribution-NonCommercial-NoDerivs CC BY-NC-ND
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAdrenal crisis
dc.subjectAdrenal insufficiency
dc.subjectBisphosphonate
dc.subjectZoledronic acid
dc.titleAdrenal Crisis as An Adverse Reaction to Zoledronic Acid in a Patient With Primary Adrenal Insufficiency: A Case Report and Literature Review
dc.typeText
dc.type.genreJournal article
dc.contributor.groupTemple University. Hospital
dc.description.departmentInternal Medicine
dc.description.departmentEndocrinology, Diabetes, and Metabolism
dc.relation.doihttps://doi.org/10.1016%2Fj.aace.2022.12.003
dc.ada.noteFor Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu
dc.description.schoolcollegeLewis Katz School of Medicine
dc.description.sponsorTemple University Libraries Open Access Publishing Fund, 2022-2023 (Philadelphia, Pa.)
dc.creator.orcidKuo|0000-0001-8629-115X
dc.creator.orcidVaz Wicks|0000-0002-6077-7079
dc.temple.creatorKuo, Bryan
dc.temple.creatorKoransky, Alison
dc.temple.creatorVaz Wicks, Cherie Lisa
refterms.dateFOA2023-09-13T16:51:22Z


Files in this item

Thumbnail
Name:
KuoEtAl-JournalArticle-2023-03.pdf
Size:
242.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND